Creative Biolabs transforms complex biological samples into high-purity, clinical-grade materials, achieving endotoxin levels as low as 0.1 EU/mg. Our service identifies molecular "masking" interactions, such as ionic attraction, hydrophobic bonding, or physical entrapment, between your target and lipopolysaccharides (LPS). By selecting the optimal resin chemistry to disrupt these specific bonds, we ensure effective purification while preserving your protein's tertiary structure and biological activity. This precision prevents "pyrogenic surprises," ensuring therapeutic candidates proceed smoothly to preclinical trials without confounding immune variables.
Endotoxins are integral components of the outer membrane of gram-negative bacteria. During the manufacturing of recombinant proteins, plasmid DNA (pDNA), and bacteriophages, these contaminants are frequently co-purified with the target product. For researchers in immunotherapy and vaccine development, "low endotoxin" is a strict regulatory requirement. Current standards set the highest permitted amount at 5.0 EU/kg/h for intravenous and 0.2 EU/kg/h for intrathecal products. Standard methods like simple filtration often fail because endotoxins can form varied micellar structures depending on the pH, ionic strength, and presence of divalent cations (like Ca2+ and Mg2+) in the buffer.
Creative Biolabs provides a specialized portfolio of de-pyrogenation strategies tailored to the unique physicochemical profiles of diverse biologics. Our offerings go beyond standard filtration, focusing on high-recovery yields and the absolute maintenance of target functionality.
We offer a broad selection of ligands, including immobilized polymyxin B, L-histidine, poly-L-lysine, and advanced high-affinity synthetic ligands. This allows us to match the right chemistry to your specific protein or viral vector.
Our platform includes specialized systems, which are specifically engineered to detach endotoxins from proteins or bacteriophages even in the presence of calcium or other divalent cations.
For ultra-pure requirements, we offer multi-step chromatographic sequences combining anion exchange (AEC) with hydrophobic interaction chromatography (HIC) or size exclusion (SEC) to ensure zero trace contamination.
We provide specialized protocols for crude lysates and fermentation broths, integrating ultrafiltration with chromatography to handle high initial endotoxin titers while protecting the target molecule.
Every offering is backed by rigorous testing using kinetic LAL, EndoLISA, or recombinant factor C (rFC) assays, providing complete transparency and data integrity for your regulatory documentation.
Explore Our Full Range of Offerings - Request a Service Brochure
The transition from a crude lysate or complex biological fluid to a pyrogen-free final product involves a rigorous, data-driven sequence designed for maximum recovery and minimal contamination risk.
Creative Biolabs stands at the intersection of bioprocess engineering and immunology. Our unique advantage lies in our ability to handle "difficult" proteins that are sensitive to traditional de-pyrogenation methods. Unlike standard filtration techniques, our chromatography-based approach accounts for the supramolecular behavior of LPS, which can shift between monomers and large micelles depending on the buffer environment. We utilize non-leaching, high-stability ligands and "published data" driven protocols to ensure no secondary toxicity is introduced to your sample. By choosing Creative Biolabs, you gain access to a platform capable of stripping endotoxins from sensitive phage tail fibers and therapeutic antibodies while maintaining 90%+ recovery rates.
Experience the Creative Biolabs Advantage – Get a Detailed Quote Today
Our methods are designed to be "gentle" and pH-optimized. Creative Biolabs selects resins and elution buffers that match your protein's stability profile to ensure maximum bioactivity retention.
We utilize specialized pre-treatment buffers to dissociate LPS from the protein surface and employ sensitive EndoLISA or rFC assays that are less prone to protein interference.
We use advanced, non-toxic ligands with higher binding capacities and significantly lower leaching rates than standard Polymyxin B, ensuring a safer and more stable final product.
To complement your purification and characterization needs, Creative Biolabs offers:
Creative Biolabs provides certified analytical and bioassay services. We deliver testing for antibody release and characterization, ensuring accurate, traceable data for biosimilar development.
Learn More →Creative Biolabs provides end-to-end antibody screening and characterization, profiling structure, and PTMs. We deliver actionable data to ensure purity, stability, and safety, accelerating lead candidate success.
Learn More →Creative Biolabs offers a premier chromatography assay that combines technical expertise with high-performance platforms to deliver ultra-pure biologics. Whether you are working with sensitive antibodies or complex phages, our tailored workflows ensure your project moves forward without the risk of pyrogenic contamination.
For detailed information or to discuss your specific project requirements, please reach out to our scientific team.